calcipotriene (dovonex) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
7Z-Calcipotriol is an isomeric impurity in vitamin D analog calcipotriol. Synthesis of 7Z-Calcipotriol was disclosed by Japanese company Kuraray Co in a patent application JP 06316558.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Topical
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.1810 - $13.1546
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( betamethasone (celestone), calcipotriene (dovonex) - other name: enstilar )

Alternative names

1,24(oh)2-22-ene-24-cyclopropyl d3 | (5e)-calcipotriene | 9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5z,7e,22e)- | betamethasone 17-valerate - clioquinol | betamethasone 17-valerate, clioquinol drug combination | betamethasone 17-valerate - neomycin | betamethasone 17-valerate, neomycin drug combination | betamethasone dipropionate and salicylic acid drug combination | betamethasone dipropionate, calcipotriol drug combination | betamethasone dipropionate - salicylic acid | betamethasone dipropionate, salicylic acid drug combination | betnovate-c | betnovate-n | bristol-myers squibb brand of calcipotriene | calcipotriene | calcipotriene hydrate | calcipotriol | calcipotriol hydrate | calciptriol | csl brand of calcipotriene | daivobet | daivonex | diprosalic | dovobet | dovonex | enstilar | farmacusi brand of calcipotriene | heximar win care | leo brand of calcipotriene | mc 903 | mc-903 | pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)-, mixt. with 2-hydroxybenzoic acid | pri-2205 | psorcutan | schering brand of calcipotriene | senosiain brand of calcipotriene | sorilux | u0267 | xamiol | xamiol gel

Organizations (160)

Research & Development (147)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (18)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (30)

Approved Indications (1)


 

Psoriasis

Experimental Indications - Clinical Trial Phases 1-4 (30)


 

Acne Vulgaris (Phase 2/Phase 3)

Alopecia (Early Phase 1)

Arthritis (Phase 1/Phase 2)

Breast Neoplasms (Phase 1)

Carcinoma, Basal Cell (Phase 2/Phase 3)

Carcinoma, Squamous Cell (Phase 2/Phase 3)

Colonic Neoplasms ()

Coronary Artery Disease (Phase 4)

Dermatitis, Atopic (Phase 2)

Dermatitis, Photoallergic (Phase 1)

Dermatitis, Phototoxic (Phase 1)

Dermatology (Phase 1)

Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)

Eczema (Phase 2)

Healthy Volunteers (Phase 1)

Inflammation (Phase 4)

Irritants (Phase 1)

Keratosis, Actinic (Phase 1)

Lung Neoplasms ()

Mesenchymal Stem Cells (Phase 1/Phase 2)

Pharmacokinetics (Phase 1/Phase 2)

Pruritus (Phase 2)

Psoriasis ()

Radiodermatitis (Phase 2)

Scleroderma, Systemic (Phase 1)

Skin and Connective Tissue Diseases (Phase 4)

Skin Diseases (Phase 4)

Skin Diseases, Papulosquamous (Phase 4)

Vasoconstriction (Phase 1)

Vitiligo (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 131
  • # of Trial Organizations: 147

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue